Midweek M&A Madness
Here are some potential target ideas, rumored or official, to jumpstart your deal pipeline. Our sources are various news reports and the Buyouts “Seeking Buyers” list. For prior lists, see below. Allied Capital is selling Callidus Capital Management, its high yield, high risk loan unit, Bloomberg reported. The unit has $3.8 billion under management. AutoImmune Inc., a Pasadena-based biopharmaceutical company involved in the development of treatments for inflammatory disease, has retained Junewicz & Co. as its financial advisor for the evaluation of strategic alternatives. IMS Health has retained Deutsche Bank Securities as its financial advisor as its explores strategic alternatives. Reuters reported that IMS had received an initial round of bids last week and that it might make a decision as early as November on whether to sell the company. The report stated that Private equity firm TPG TPG.UL had submitted an offer and that Silver Lake and BC Partners had submitted a joint bid.
